These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1412640)

  • 1. The activity in vitro of cycloguanil and pyrimethamine in combination against Plasmodium falciparum.
    Yeo AE; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1992; 86(3):234. PubMed ID: 1412640
    [No Abstract]   [Full Text] [Related]  

  • 2. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
    Watkins WM; Sixsmith DG; Chulay JD
    Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Ramiliarisoa O; Le Bras J
    Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates.
    Schapira A
    Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine.
    Gyang FN; Peterson DS; Wellems TE
    Exp Parasitol; 1992 Jun; 74(4):470-2. PubMed ID: 1592095
    [No Abstract]   [Full Text] [Related]  

  • 8. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
    Foote SJ; Galatis D; Cowman AF
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
    Pinheiro L; Rosário VE
    Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies.
    Bhasin VK; Nair L
    Jpn J Med Sci Biol; 1996 Feb; 49(1):1-14. PubMed ID: 8799803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors.
    Sixsmith DG; Watkins WM; Chulay JD; Spencer HC
    Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
    Childs GE; Lambros C
    Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
    Ang HH; Cheang HS; Mak JW
    Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.
    Ang HH; Lam CK; Wah MJ
    Chemotherapy; 1996; 42(5):318-23. PubMed ID: 8874969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
    Ang HH; Chan KL; Mak JW
    J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro.
    Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC
    Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil.
    Petersen E; Hogh B; Hanson AP; Bjorkman A; Flacks H
    Ann Trop Med Parasitol; 1990 Dec; 84(6):563-71. PubMed ID: 2076034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
    Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
    Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
    Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
    Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.